SEP 17, 2020 7:00 AM PDT

COVID Vaccine Works in Macaques - What about in Humans?

WRITTEN BY: Tara Fernandez

Pharmaceutical giant Pfizer, in partnership with BioNTech has reported that one of its lead vaccine candidates has shown promising results in protecting animals against coronavirus infections. The experimental vaccine, BNT162b2, is distinct from other commercially-available vaccines in that it is in an mRNA format, an RNA version of the gene that travels from the nucleus to the cell cytoplasm where proteins are made.

In a recent study, the companies published that the vaccine, once injected into macaques and mice, produced antibodies that neutralized SARS-CoV-2, thus protecting against the symptoms of COVID-19. One shot was given to the animals together with a booster shot, which protected them from the coronavirus, compared to the unvaccinated animals which became infected. It also launched an immune response via the activation of T cells in the macaques, which together formed a strong antiviral shield. The results were published in BioRxiv.

Does this mean a vaccine that will protect humans against COVID-19 is around the corner? For now, it’s still up in the air. Recently, competitor AstraZeneca had to pump the brakes on the clinical trial of their COVID vaccine after a participant in the trial suffered serious neurological side effects after being injected with it. The difference between this vaccine and BNT162b2 is that the latter uses a potentially safer mRNA approach, providing some cause for optimism.

Massive clinical trials to test the efficacy and safety of experimental COVID-19 vaccines are currently underway. J&J, for example, has 60,000 people lined up to test their vaccine frontrunner, which showed similarly robust protective effects in primate studies.

Pfizer and BioNTech are pushing forward with the validation of BNT162b2, enrolling over 25,000 around the world who will receive the experimental treatment.

 

Source: Fierce Biotech.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 12, 2020
Immunology
Disabling Genes in Immune Cells Prevents Obesity
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
MAY 08, 2020
Immunology
Vaccine Prevents Virally-induced Type 1 Diabetes
MAY 08, 2020
Vaccine Prevents Virally-induced Type 1 Diabetes
Scientists aren’t exactly sure what causes type 1 diabetes, although genetics and environmental factors are presum ...
JUN 18, 2020
Neuroscience
How Climate Change Worsened Zika Virus Defects
JUN 18, 2020
How Climate Change Worsened Zika Virus Defects
Image: Pixabay   In 2015 a massive outbreak of the Zika virus started in Brazil and spread across 33 countries. The ...
JUL 09, 2020
Immunology
Why COVID Herd Immunity Is Important but Impossible
JUL 09, 2020
Why COVID Herd Immunity Is Important but Impossible
The number of confirmed COVID-19 cases worldwide is steadily approaching 12 million. Meanwhile, despite accelerated time ...
JUL 10, 2020
Drug Discovery & Development
Injection 66% Better than Daily Pill to Prevent HIV
JUL 10, 2020
Injection 66% Better than Daily Pill to Prevent HIV
Pharmaceutical company ViiV Healthcare has announced that its long-lasting, injectable drug, cabotegravir, is more effec ...
AUG 19, 2020
Cell & Molecular Biology
Mild COVID-19 Cases Induce an Immune Cell Response
AUG 19, 2020
Mild COVID-19 Cases Induce an Immune Cell Response
As the pandemic virus, SARS-CoV-2 continues to cause tens of thousands of new cases of COVID-19 every day in the United ...
Loading Comments...